0001209191-23-057640.txt : 20231206 0001209191-23-057640.hdr.sgml : 20231206 20231206170547 ACCESSION NUMBER: 0001209191-23-057640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231204 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVIN JEREMY M CENTRAL INDEX KEY: 0001256153 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 231470404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 441 NINTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 441 NINTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-04 0 0001636651 Ovid Therapeutics Inc. OVID 0001256153 LEVIN JEREMY M C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE NEW YORK NY 10001 1 1 0 0 CEO 0 Common Stock 2023-12-04 4 G 0 573275 0.00 D 4171742 D Common Stock 2023-12-04 4 G 0 573275 0.00 D 3598467 D Common Stock 35461 I See Footnote The reporting executive has transferred shares to a family trust for the benefit of his children as part of generational estate planning. The reporting executive has made these transfers for no consideration. The reporting executive does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares. This direct ownership total corrects an inadvertent administrative error in the number of shares of common stock that were reported as directly held on the Form 4 filed by the reporting executive on September 1, 2020. Before the transactions reported herein, the reporting executive held 4,745,017 shares of common stock directly The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The reporting executive's spouse is the manager of Divo. The reporting executive disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose. /s/ Danielle Mann for Jeremy Levin PoA 2023-12-06